Pregled bibliografske jedinice broj: 87973
Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay
Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay // 31st Annual Meeting of European Environment Mutagen Society : Abstracts
Ghent, 2001. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 87973 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay
Autori
Kopjar, Nevenka ; Garaj-Vrhovac, Vera ; Milas, Ivan
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
31st Annual Meeting of European Environment Mutagen Society : Abstracts
/ - Ghent, 2001
Skup
31st Annual Meeting of European Environment Mutagen Society
Mjesto i datum
Gent, Belgija, 01.09.2001. - 05.09.2001
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
comet assay; Ieukocytes; antineoplastic drugs; interindividual variations; DNA damage
Sažetak
The alkaline comet assay was employed to assess the pre- and post-treatment Ievels of in vivo DNA damage in peripheral blood Ieukocytes of twelve cancer patients. During study all patients were given antineoplastic drugs, mainly as polychemotherapy. To quantify the DNA damage the comet taillength and the tail moment were evaluated. Our results indicate marked interindividual variations between baseline DNA damage in peripheral blood Ieukocytes recorded among cancer patients prior to the chemotherapy. After intravenous administration of various antineoplastic drugs a significantly increased Ievel of DNA damage in all cancer patients compared to their pre-treatment values was recorded. The highest Ievel of DNA damage was pronounced in a patient received antineoplastic drugs according to COPP/ABV protocol. Despite of their Iimitations, our results confirm the usefulness of the alkaline comet assay as a sensitive biomarker of exposure that enables rapid and simple detection of primary DNA damage in peripheral blood Ieukocytes of cancer patients. Together with standard cytogenetic endpoints comet assay provides a powerful technique for the routine detection of critical DNA Iesions produced after administration of antineoplastic drugs in the clinical settings.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
00220107
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb